Don't Use Baloxavir to Treat Patients Hospitalized With the Flu
December 2018
Baloxavir (Xofluza, zoh-FLOO-zuh) will be the first new oral antiviral for treating influenza in nearly 20 years.
Think of baloxavir as an alternative to oseltamivir (Tamiflu)...but with a new antiviral mechanism. Both baloxavir and oseltamivir reduce flu symptoms by about a day in otherwise healthy patients...if started within 48 hours of onset.
But baloxavir is ONE oral dose...compared to 5 days of BID oseltamivir. Baloxavir also seems to cause less nausea and vomiting.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote